This page lists all pharmaceutical reports related to the field of Infectious Diseases. The reports include market research reports and pipeline analyses.
- Anti-Infectives: World Market for Antifungals
- The Worldwide Market for Dialysis Equipment, Supplies, and Services
- Vaccines: The World Market
- Womens Health: Worldwide Prescription Drug Markets
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Mens Health: The Market for Current and Emerging Drug Therapies
- The Global Market for Adjunctive Therapies in Cancer
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
- HIV: A Strategic Analysis of Therapeutic and Testing Markets
- The Worldwide Market for Prescription Dermatological Drugs
- The U.S. Market for Over-the-Counter Anti-Infectives
- Anti Infectives: Antibacterials
- Women's Health: Diagnostic Tests
- Cytology and HPV Testing World Markets
- Pharmacogenomic Testing Markets
- Avian Influenza: The Threatening Pandemic
- World market for cancer vaccines 2007-2012
- Stakeholder Opinions: Nosocomial Infections - The need for new gram-negative drugs
- Global Tuberculosis Strategies
- Early Toxicology: Markets and Approaches
- Pipeline and Commercial Insight: Influenza Vaccines - Pandemic threat revitalizes the sector
- HIV - Change of guard
- Respiratory Syncytial Virus (RSV) - A market yet to reach its full potential
- Antibacterials - Growth in resistance rates drives niche indications
- Respiratory Tract Infections in the USA
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Pipeline Insight: HIV - Extending treatment options
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Rheumatoid Arthritis
- Biogenerics
- Sepsis - Under reaction to an overreaction
- Antiviral Therapeutics - technologies, markets and companies
- The Global Antivirals Market
- Influenza Vaccines
- Therapeutic Vaccines
- Stakeholder Insight: Hepatitis in China
- Sexually Transmitted Infections
- Herpes and Respiratory Antivirals
- Stakeholder Insight: HIV
- Commercial Insight: HIV
- Commercial Insight: Antibacterials
- Tropical and Defense Vaccines - The Scared, the Weak and the Poor
- Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution?
- Pipeline Insight: Hepatitis B
- Pipeline Insight: HIV
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- HIV - Benchmarking Rapid Antiretroviral Uptake
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Advanced Life Sciences' Cethromycin - Phase III success should allow 'me-too' market entry
- Pipeline Insight: Hepatitis C - Protease inhibitors to drive market expansion
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Drug Discovery Tools for High-Content Analysis
- The Women’s Health Market Outlook to 2011
- The Global Anti-Infectives Market Outlook to 2011
- Antibiotics and Drug Resistance 2008: New drug innovation and the strategy to combat antibiotic resistance mechanisms
- Animal Health Products Antibacterials Markets
- Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines
- Commercial Insight: HIV - Reshaping Treatment Paradigms
- The Global Anti-Infectives Market Outlook to 2011
- GINGIVITIS and PERIODONTITIS - Therapy Area Pipeline Report
- SKIN INFECTIONS, DERMATOSIS and SKIN ITCHING - Therapy Area Pipeline Report
- BACTERIAL INFECTIONS - Therapy Area Pipeline Report
- AIDS and HIV INFECTION - Therapy Area Pipeline Report
- EAR INFECTIONS - Therapy Area Pipeline Report
- FEVER - Therapy Area Pipeline Report
- FUNGAL INFECTIONS and CANDIDIASIS - Therapy Area Pipeline Report
- HELMINTHIC INFESTATIONS - Therapy Area Pipeline Report
- HEPATITIS B - Therapy Area Pipeline Report
- HEPATITIS C - Therapy Area Pipeline Report
- HERPES SIMPLEX VIRUS INFECTION - Therapy Area Pipeline Report
- INFLUENZA - Therapy Area Pipeline Report
- MALARIA - Therapy Area Pipeline Report
- PNEUMONIA - Therapy Area Pipeline Report
- STAPHYLOCOCCAL INFECTIONS - Therapy Area Pipeline Report
- URINARY TRACT INFECTIONS - Therapy Area Pipeline Report
- VAGINAL INFECTIONS - Therapy Area Pipeline Report
- VIRAL INFECTIONS - Therapy Area Pipeline Report
- The Global HIV/AIDS Market Outlook to 2012
- Peripheral Neuropathy and Neuropathic Pain, 2008
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Commercial and Pipeline Insight: Hepatitis B
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- HIV Therapy: Prescription trends, Markets and Unmet Needs
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The Global Antibacterials Market
- Pipeline and Commercial Insight: Systemic antifungals
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Hepatitis B (HBV) - Commercial and Pipeline Insight
- Pediatric Drugs - the Worldwide Market
- HIV Resistance: Impact and Evolution
- Respiratory Syncytial Virus: Can Antivirals Make the Grade?
- Stakeholder Insight: Invasive Fungal Infections - Options Outweigh Replacements
- Commercial Perspectives: Vaccines - Nosocomial Pathogens
- Commercial Perspectives: Fluoroquinolones - Established Products Drive Market Growth
- Commercial Insight: Hepatitis B and C - Awaiting New Developments
- Stakeholder Opinions: Community Acquired Respiratory Tract Infections - Room for Ketek?
- Pipeline Insight: HIV - Enter the New Generation Inhibitors
- Stakeholder Opinions: Skin Infections - Where In The Antibacterial Lifecycle?
- Commercial Insight: HIV - From the Naive to the Complex
- Stakeholder Insight: HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
- Commercial Insight: Vaccines - Reaching Adulthood
- Stakeholder Opinions: Urinary Tract Infections - Ciprofloxacin Leads the Way
- Stakeholder Insight: Hepatitis B & C - Winning Battles But Not The War
- Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes
- Commercial Insight: Antibacterials - Regulations, Resistance & Generics
- Commercial Insight: Antifungals - More Data, More Prescriptions
- The Antivirals Outlook to 2007: Marketing opportunities by disease state, patient potential and product profile
- The World Market for Vaccines
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- The Worldwide Market for Prescription Dermatological Drugs - 4th Edition
- Gene Expression Profiling Markets
- Hepatitis C - Small-molecule antivirals pave the way for triple therapy
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- How to Conduct Clinical Trials in China
- Prescription Dermatological Drugs: Worldwide Market
- Commercial Insight: Infectious Diseases
- Launching Combination Products: Brand extension and franchise development strategies
- Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Vaccines: Market Analysis, Key Players, and Critical Trends
- Sepsis - Clinical and commercial developments
- Biologics in Infectious Diseases
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Pipeline Insight: Nosocomial Vaccines
